AtaiBeckley Inc (ATAI)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$7.350.00%
Close 2026-09-11 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · ATAI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -5.2% |
| Our one-year growth estimate | diamond | -29.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 24.8 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has been missing across recent quarters and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers · Company calendar date is not available
ATAI — legal / regulatory event — On the Closing Date, the Company (i) notified The Nasdaq Stock Market LLC (“…
Dated 2026-09-11
On the Closing Date, the Company (i) notified The Nasdaq Stock Market LLC (“ Nasdaq ”) of the consummation of the Merger and (ii) requested that Nasdaq (x) suspend trading of the Common Stock and (y) file with the SEC a Form 25, Notification of Removal from Listing and/or Registration, to delist the Common Stock from Nasdaq and deregister the Common Stock under Section 12(b) of the Exchange Act. Following the effectiveness of the Form 25, the Company intends to file with the SEC a Certificati…
Why it matters: The deal sets a $1.00-per-share cash payment if VLS-01 gains U.S. approval and DEA rescheduling within seven years after closing.
Supportive ifLilly or a public filing confirms both U.S. approval and DEA rescheduling for VLS-01 by September 11, 2033.
Worry ifVLS-01 lacks either U.S. approval or DEA rescheduling by September 11, 2033.
Why it matters: The deal sets a $0.50-per-share cash payment if BPL-003 gains U.S. approval and DEA rescheduling within five years after closing.
Supportive ifLilly or a public filing confirms both U.S. approval and DEA rescheduling for BPL-003 by September 11, 2031.
Worry ifBPL-003 lacks either U.S. approval or DEA rescheduling by September 11, 2031.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$81 on $10,000 · ±0.8% | How much price usually moves either way. |
| Bad day | $611 loss on $10,000 · 6.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,806 loss on $10,000 · 48.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.